Amsterdam-based information products giant Elsevier has gobbled up Ariadne Genomics, a company that provides software allowing researchers to study molecular pathways and disease progression. With scientists facing a deluge of data from a number of publications, Rockville, MD-based Ariadne's software uses semantics technologies to tap multiple content sources for material on molecular pathways and disease progression, according to Elsevier. Ariadne, with its main product Pathway Studio, is expected to become part of the buyer's Corporate Markets unit, but financial terms of the deal, which was announced Dec. 8, weren't disclosed. Release
